...
abvc-img

ABVC Biopharma Inc, Common Stock

ABVC

NAQ

$0.521

+$0.04

(8.25%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$5.94M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
169.75K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.82
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.41 L
$2.45 H
$0.521

About ABVC Biopharma Inc, Common Stock

ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase II clinical trials a combination therapy for triple negative breast cancer; ABV-1504 has completed Phase II clinical trials for major depressive disorders; ABV-1505, which is in Phase II clinical trials for adult attention deficit hyperactivity disorder; ABV-1703, which is in Phase II clinical trials for the treatment of metastatic pancreatic cancer; ABV-1702, which is in Phase II clinical trials to treat myelodysplastic syndromes; and ABV-1601 that is in Phase I/II clinical trials for treating depression in cancer patients. It is also developing ABV-1701 Vitargus that is in Phase II clinical trials for the treatment of retinal detachment or vitreous hemorrhage; and ABV-1519, which is in Phase I/II clinical trials for the treatment of non-small cell lung cancer. ABVC BioPharma, Inc. has a co-development agreement with Rgene Corporation; and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company is based in Fremont, California. ABVC BioPharma, Inc. operates as a subsidiary of YuanGene Corporation. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameABVCSectorS&P500
1-Week Return-6.69%-3.39%-3.47%
1-Month Return-4.98%-3.25%-0.29%
3-Month Return-26.52%-11.61%4.5%
6-Month Return-32.87%-5.89%6.91%
1-Year Return-58.9%2.65%23.79%
3-Year Return-98.65%0.56%28.43%
5-Year Return-99.11%34.63%83.64%
10-Year Return-99.98%94.78%185.94%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue701.72K483.05K355.80K969.78K152.43K[{"date":"2019-12-31","value":72.36,"profit":true},{"date":"2020-12-31","value":49.81,"profit":true},{"date":"2021-12-31","value":36.69,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":15.72,"profit":true}]
Cost of Revenue20.14K18.72K5.09K286.42K302.04K[{"date":"2019-12-31","value":6.67,"profit":true},{"date":"2020-12-31","value":6.2,"profit":true},{"date":"2021-12-31","value":1.68,"profit":true},{"date":"2022-12-31","value":94.83,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit681.58K464.33K350.71K683.37K(149.61K)[{"date":"2019-12-31","value":99.74,"profit":true},{"date":"2020-12-31","value":67.95,"profit":true},{"date":"2021-12-31","value":51.32,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-21.89,"profit":false}]
Gross Margin97.13%96.13%98.57%70.47%(98.15%)[{"date":"2019-12-31","value":98.54,"profit":true},{"date":"2020-12-31","value":97.52,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":71.49,"profit":true},{"date":"2023-12-31","value":-99.57,"profit":false}]
Operating Expenses4.14M8.97M11.70M15.80M8.07M[{"date":"2019-12-31","value":26.21,"profit":true},{"date":"2020-12-31","value":56.78,"profit":true},{"date":"2021-12-31","value":74.03,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":51.06,"profit":true}]
Operating Income(3.46M)(8.51M)(11.35M)(15.11M)(8.22M)[{"date":"2019-12-31","value":-345877800,"profit":false},{"date":"2020-12-31","value":-850577600,"profit":false},{"date":"2021-12-31","value":-1134507000,"profit":false},{"date":"2022-12-31","value":-1511441200,"profit":false},{"date":"2023-12-31","value":-821650900,"profit":false}]
Total Non-Operating Income/Expense(1.01M)(2.64M)311.13K(506.33K)(4.75M)[{"date":"2019-12-31","value":-324.68,"profit":false},{"date":"2020-12-31","value":-849.22,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-162.74,"profit":false},{"date":"2023-12-31","value":-1525.3,"profit":false}]
Pre-Tax Income(4.01M)(10.81M)(11.21M)(15.51M)(10.65M)[{"date":"2019-12-31","value":-401028100,"profit":false},{"date":"2020-12-31","value":-1081393600,"profit":false},{"date":"2021-12-31","value":-1121082700,"profit":false},{"date":"2022-12-31","value":-1551459600,"profit":false},{"date":"2023-12-31","value":-1065428200,"profit":false}]
Income Taxes(77.04K)(220.35K)825.02K797.78K256.01K[{"date":"2019-12-31","value":-9.34,"profit":false},{"date":"2020-12-31","value":-26.71,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":96.7,"profit":true},{"date":"2023-12-31","value":31.03,"profit":true}]
Income After Taxes(3.93M)(10.59M)(12.04M)(16.31M)(10.91M)[{"date":"2019-12-31","value":-393324000,"profit":false},{"date":"2020-12-31","value":-1059358400,"profit":false},{"date":"2021-12-31","value":-1203585100,"profit":false},{"date":"2022-12-31","value":-1631237400,"profit":false},{"date":"2023-12-31","value":-1091028800,"profit":false}]
Income From Continuous Operations(3.93M)(10.59M)(12.04M)(16.31M)(10.91M)[{"date":"2019-12-31","value":-393324000,"profit":false},{"date":"2020-12-31","value":-1059358400,"profit":false},{"date":"2021-12-31","value":-1203585100,"profit":false},{"date":"2022-12-31","value":-1631237400,"profit":false},{"date":"2023-12-31","value":-1091028800,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(3.93M)(10.59M)(12.04M)(16.31M)(10.52M)[{"date":"2019-12-31","value":-393324000,"profit":false},{"date":"2020-12-31","value":-1059358400,"profit":false},{"date":"2021-12-31","value":-1203585100,"profit":false},{"date":"2022-12-31","value":-1631237400,"profit":false},{"date":"2023-12-31","value":-1051565600,"profit":false}]
EPS (Diluted)(0.22)(0.51)(0.51)(0.52)(1.95)[{"date":"2019-12-31","value":-21.6,"profit":false},{"date":"2020-12-31","value":-51.49,"profit":false},{"date":"2021-12-31","value":-51,"profit":false},{"date":"2022-12-31","value":-52,"profit":false},{"date":"2023-12-31","value":-195.4,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

ABVC
Cash Ratio 0.03
Current Ratio 0.34
Quick Ratio 0.36

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

ABVC
ROA (LTM) -44.55%
ROE (LTM) -320.36%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

ABVC
Debt Ratio Lower is generally better. Negative is bad. 0.45
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.58

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

ABVC
Trailing PE NM
Forward PE NM
P/S (TTM) 43.54
P/B 0.71
Price/FCF 35
EV/R 15.72
EV/Ebitda NM

FAQs

What is ABVC Biopharma Inc share price today?

ABVC Biopharma Inc (ABVC) share price today is $0.521

Can Indians buy ABVC Biopharma Inc shares?

Yes, Indians can buy shares of ABVC Biopharma Inc (ABVC) on Vested. To buy ABVC Biopharma Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ABVC stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of ABVC Biopharma Inc be purchased?

Yes, you can purchase fractional shares of ABVC Biopharma Inc (ABVC) via the Vested app. You can start investing in ABVC Biopharma Inc (ABVC) with a minimum investment of $1.

How to invest in ABVC Biopharma Inc shares from India?

You can invest in shares of ABVC Biopharma Inc (ABVC) via Vested in three simple steps:

  • Click on Sign Up or Invest in ABVC stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in ABVC Biopharma Inc shares
What is ABVC Biopharma Inc 52-week high and low stock price?

The 52-week high price of ABVC Biopharma Inc (ABVC) is $2.45. The 52-week low price of ABVC Biopharma Inc (ABVC) is $0.41.

What is ABVC Biopharma Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of ABVC Biopharma Inc (ABVC) is

What is ABVC Biopharma Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of ABVC Biopharma Inc (ABVC) is 0.71

What is ABVC Biopharma Inc dividend yield?

The dividend yield of ABVC Biopharma Inc (ABVC) is 0.00%

What is the Market Cap of ABVC Biopharma Inc?

The market capitalization of ABVC Biopharma Inc (ABVC) is $5.94M

What is ABVC Biopharma Inc’s stock symbol?

The stock symbol (or ticker) of ABVC Biopharma Inc is ABVC

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top